RGEN
Repligen Corporation
NasdaqGS
People also watch:SGMODYAXNBIXPGNXSCLN
27.500.18 (0.66%)

After hours: 27.500.00 (0.00%) as of 5:01 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close27.32
Open27.26
Bid0.00 x
Ask35.00 x 200
52wk Range20.07 - 39.17
Day's Range27.14 - 27.69
Volume107,498
Avg Vol (3m)300,420
As of 4:00 PM EDT. Market closed.
  • Repligen Corp. – Value Analysis (NASDAQ:RGEN) : July 1, 2016
    Capital Cube22 days ago

    Repligen Corp. – Value Analysis (NASDAQ:RGEN) : July 1, 2016

    Click here to see latest analysisCapitalcube gives Repligen Corp. a score of 88.Our analysis is based on comparing Repligen Corp. with the following peers – Novavax, Inc., Neurocrine Biosciences, Inc., BioMarin Pharmaceutical Inc., Charles River Laboratories International, Inc., Thermo Fisher Scientific Inc., Caladrius Biosciences, Inc., Bristol-Myers Squibb Company, Sangamo BioSciences, Inc., Pfizer Inc. and General […] (Read more...) The post Repligen Corp. – Value Analysis (NASDAQ:RGEN) : July 1, 2016 appeared first on CapitalCube.

  • Repligen (RGEN) in Focus: Stock Adds 6.9% in Session
    Zacks23 days ago

    Repligen (RGEN) in Focus: Stock Adds 6.9% in Session

    Repligen Corporation (RGEN) was a big mover last session, as the company saw its shares rise nearly 7% on the day.